Randomized chemotherapy versus autologous transplantation, measured from time of randomization. (A) Event-free survival for all patients. (B) Overall survival for all (C) high-risk patients and (D) standard-risk patients. (E) Nonrelapse mortality for all patients undergoing chemotherapy or autologous transplantation.